Overview

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

Status:
Recruiting

Trial end date:
2022-02-12

Target enrollment:

Participant gender:

Summary

This study will evaluate the proportion of patients achieving confirmed SVR12 (undetectable HCV RNA at time point 12 weeks plus post treatment commencement) in patients hospitalised for IRID (injecting related infectious diseases) and commencing inpatient DAA treatment within public hospital services.

Phase:

N/A

Details

Lead Sponsor:

Kirby Institute

Treatments:

Sofosbuvir